These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 7893785

  • 1. The effect of a thromboxane A2 synthase inhibitor on the dyslipoproteinemia of an inbred rat strain with spontaneous age-related nephrotic syndrome.
    Tarugi P, Nicolini S, Albertazzi L, Marchi L, Calandra S, Salvati P.
    Aging (Milano); 1994 Oct; 6(5):381-90. PubMed ID: 7893785
    [Abstract] [Full Text] [Related]

  • 2. Dyslipoproteinemia in an inbred rat strain with spontaneous chronic progressive nephrotic syndrome.
    Tarugi P, Nicolini S, Albertazzi L, Calandra S, Salvati P, Ferti C, Patrono C.
    J Lipid Res; 1991 Oct; 32(10):1675-87. PubMed ID: 1797947
    [Abstract] [Full Text] [Related]

  • 3. Plasma and urine lipoproteins during the development of nephrotic syndrome induced in the rat by adriamycin.
    Calandra S, Tarugi P, Ghisellini M, Gherardi E.
    Exp Mol Pathol; 1983 Dec; 39(3):282-99. PubMed ID: 6416889
    [Abstract] [Full Text] [Related]

  • 4. Role of enhanced glomerular synthesis of thromboxane A2 in progressive kidney disease.
    Salvati P, Ferti C, Ferrario RG, Lamberti E, Duzzi L, Bianchi G, Remuzzi G, Perico N, Benigni A, Braidotti P.
    Kidney Int; 1990 Sep; 38(3):447-58. PubMed ID: 2232487
    [Abstract] [Full Text] [Related]

  • 5. Long-term thromboxane-synthase inhibition prolongs survival in murine lupus nephritis.
    Salvati P, Lamberti E, Ferrario R, Ferrario RG, Scampini G, Pugliese F, Barsotti P, Patrono C.
    Kidney Int; 1995 Apr; 47(4):1168-75. PubMed ID: 7783415
    [Abstract] [Full Text] [Related]

  • 6. Lipoprotein distribution and composition in the human nephrotic syndrome.
    Muls E, Rosseneu M, Daneels R, Schurgers M, Boelaert J.
    Atherosclerosis; 1985 Feb; 54(2):225-37. PubMed ID: 3986019
    [Abstract] [Full Text] [Related]

  • 7. Effect of lipid transfer protein on plasma lipids, apolipoproteins and metabolism of high-density lipoprotein cholesteryl ester in the rat.
    Groener JE, van Gent T, van Tol A.
    Biochim Biophys Acta; 1989 Mar 14; 1002(1):93-100. PubMed ID: 2493808
    [Abstract] [Full Text] [Related]

  • 8. Action of atorvastatin in combined hyperlipidemia : preferential reduction of cholesteryl ester transfer from HDL to VLDL1 particles.
    Guerin M, Lassel TS, Le Goff W, Farnier M, Chapman MJ.
    Arterioscler Thromb Vasc Biol; 2000 Jan 14; 20(1):189-97. PubMed ID: 10634817
    [Abstract] [Full Text] [Related]

  • 9. Urinary excretion of apolipoproteins bound to HDL-like particles in rat nephrotic syndrome and their relation to plasma HDL.
    Shafrir E, Levy E, Deckelbaum R.
    Nephron; 1990 Jan 14; 56(1):24-9. PubMed ID: 2234246
    [Abstract] [Full Text] [Related]

  • 10. Patients with nephrotic-range proteinuria have apolipoprotein C and E deficient VLDL1.
    Deighan CJ, Caslake MJ, McConnell M, Boulton-Jones JM, Packard CJ.
    Kidney Int; 2000 Sep 14; 58(3):1238-46. PubMed ID: 10972686
    [Abstract] [Full Text] [Related]

  • 11. Acyl-coenzyme A:cholesterol acyltransferase inhibition ameliorates proteinuria, hyperlipidemia, lecithin-cholesterol acyltransferase, SRB-1, and low-denisty lipoprotein receptor deficiencies in nephrotic syndrome.
    Vaziri ND, Liang KH.
    Circulation; 2004 Jul 27; 110(4):419-25. PubMed ID: 15262831
    [Abstract] [Full Text] [Related]

  • 12. Lipid metabolism in nephrotic rats induced by daunomycin injection.
    Morisaki N, Matsuoka N, Saito Y, Kumagai A.
    Metabolism; 1984 May 27; 33(5):405-10. PubMed ID: 6717274
    [Abstract] [Full Text] [Related]

  • 13. Plasma lipids and acyltransferase activities in experimental nephrotic syndrome.
    Sestak TL, Alavi N, Subbaiah PV.
    Kidney Int; 1989 Aug 27; 36(2):240-8. PubMed ID: 2779094
    [Abstract] [Full Text] [Related]

  • 14. Lipoprotein profiles in a heterogeneous group of patients with nephrotic syndrome.
    Michaeli J, Bar-On H, Shafrir E.
    Isr J Med Sci; 1981 Nov 27; 17(11):1001-8. PubMed ID: 7319786
    [Abstract] [Full Text] [Related]

  • 15. [Effects of a selective thromboxane A2 synthetase inhibitor, OKY-046, on proteinuria of aminonucleoside nephrotic rats].
    Suzuki S, Akama H, Kume K, Higuchi E, Kamiyama S, Suzuki J, Ohara N, Yugeta E, Kato K, Suzuki H.
    Nihon Jinzo Gakkai Shi; 1988 Apr 27; 30(4):341-6. PubMed ID: 3230687
    [No Abstract] [Full Text] [Related]

  • 16. Effects of castration and testosterone administration on serum lipoproteins and their apoproteins in male spontaneously hypertensive rat.
    Takeuchi N, Go S, Murase M, Nomura Y, Takase H, Uchida K.
    Endocrinology; 1986 May 27; 118(5):1787-94. PubMed ID: 3084207
    [Abstract] [Full Text] [Related]

  • 17. Secretion of lipoproteins, apolipoprotein A-I and apolipoprotein E by isolated and perfused liver of rat with experimental nephrotic syndrome.
    Calandra S, Gherardi E, Fainaru M, Guaitani A, Bartosek I.
    Biochim Biophys Acta; 1981 Aug 24; 665(2):331-8. PubMed ID: 6793079
    [Abstract] [Full Text] [Related]

  • 18. Nephrotic hyperlipidemia: primary abnormalities in both lipoprotein catabolism and synthesis.
    Kaysen GA.
    Miner Electrolyte Metab; 1992 Aug 24; 18(2-5):212-6. PubMed ID: 1465061
    [Abstract] [Full Text] [Related]

  • 19. Role of lipoprotein-bound NEFAs in enhancing the specific activity of plasma CETP in the nephrotic syndrome.
    Braschi S, Masson D, Rostoker G, Florentin E, Athias A, Martin C, Jacotot B, Gambert P, Lallemant C, Lagrost L.
    Arterioscler Thromb Vasc Biol; 1997 Nov 24; 17(11):2559-67. PubMed ID: 9409228
    [Abstract] [Full Text] [Related]

  • 20. The causal role of hypoalbuminemia in human nephrotic hyperlipidemia.
    Rahman M, Salamatullah Q, Ferdous Z, Hussain MA.
    Bangladesh Med Res Counc Bull; 1976 Jun 24; 2(1):64-70. PubMed ID: 190998
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.